Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Information source: California Institute of Renal Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Native Arteriovenous Fistula
Intervention: Topical Tranexamic Acid (Drug); Topical Bacitracin (Drug)
Phase: Phase 4
Status: Not yet recruiting
Sponsored by: California Institute of Renal Research Official(s) and/or principal investigator(s):
Mark Boiskin, MD, Principal Investigator, Affiliation: California Institute of Renal Research
Overall contact:
Christina Lorenzo, BS, Phone: 858-637-4600, Email: clorenzo@cairr.com
Summary
This study will investigate how the use of Tranexamic acid and Bacitracin applied to the
bleeding site after the hemodialysis fistula needle is removed will affect skin wound
healing.
Clinical Details
Official title: Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Clotting Time
Secondary outcome: Bleeding TimeBlood Loss Local Compression Time Local Infection
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Dialysis patients with fistulas (native arterio-venous)
Exclusion Criteria:
- Previous sensitivity to or adverse reaction to Tranexamic acid or Bacitracin.
- Active infection.
- Stenosis of fistula.
Locations and Contacts
Christina Lorenzo, BS, Phone: 858-637-4600, Email: clorenzo@cairr.com
California Insitute of Renal Research, San Diego, California 92123, United States; Not yet recruiting
Christina Lorenzo, BS, Phone: 858-637-4600, Email: clorenzo@cairr.com
Mark Boiskin, MD, Principal Investigator
Christian Mende, MD, Sub-Investigator
Dylan Steer, MD, Sub-Investigator
Fresenious Medical Care - Rancho, San Diego, California 92127, United States; Not yet recruiting
Buchard, Email: lbuchard@cairr.com
Mark Boiskin, MD, Principal Investigator
Christian Mende, MD, Sub-Investigator
Dylan Steer, MD, Sub-Investigator
Fresenius Medical Care - Kearny Mesa, San Diego, California 92111, United States; Not yet recruiting
Buchard, Email: lbuchard@cairr.com
Mark Boiskin, MD, Principal Investigator
Christian Mende, MD, Sub-Investigator
Dylan Steer, MD, Sub-Investigator
Additional Information
Starting date: April 2014
Last updated: April 9, 2014
|
